MIMS launches new travel health guidance

MIMS now features travel health guidance from the National Travel Health Network and Centre (NaTHNaC).

New travel health guidance in MIMS provides the latest recommendations on vaccination and malaria prophylaxis. | SCIENCE PHOTO LIBRARY
New travel health guidance in MIMS provides the latest recommendations on vaccination and malaria prophylaxis. | SCIENCE PHOTO LIBRARY

NaTHNaC was established by the Department of Health in 2002 and is now commissioned by the Health Protection Agency to develop consistent and authoritative national guidance on travel health for health professionals and to promote excellence in the practice of travel medicine, with the broad goal of Protecting the Health of British Travellers. Its clinical and scientific team compiles advice for both healthcare professionals and travellers, which is updated continuously based on daily surveillance of disease outbreaks around the world.

Latest recommendations

The MIMS/NaTHNaC travel tables are an invaluable resource for travel health consultations. The guidance is arranged by country, allowing healthcare professionals to easily find the latest official recommendations for travel to a particular destination.  It will be updated monthly.

In addition to recommendations on vaccination and malaria prophylaxis, the guidance includes:

Printable travel health fact sheets for patients are also available online.

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Roche highlights risk of neuropsychiatric reactions with Lariam

Roche highlights risk of neuropsychiatric reactions with Lariam

Roche has issued a letter to healthcare professionals...

New recommendations for malaria prevention in UK travellers

New recommendations for malaria prevention in UK travellers

Country-specific guidance on malaria risk and chemoprophylaxis...

Ixiaro: Japanese encephalitis vaccine approved for paediatric use

Ixiaro: Japanese encephalitis vaccine approved for paediatric use

Children aged 2 months and older can now receive the...

Restriction on length of Malarone use lifted

Restriction on length of Malarone use lifted

Prescribing information for Malarone and Malarone Paediatric...

Dengue vaccine results prompt both disappointment and hope

Dengue vaccine results prompt both disappointment and hope

The first vaccine against dengue fever to reach large-scale...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more